ArticleFrontiers in microbiomes2026
Placental and maternal microbiome adaptations in a preeclamptic-like mouse model.
Article in Frontiers in microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: The maternal microbiome plays a crucial role in pregnancy with growing evidence supporting vertical microbial transmission from mother to fetus. The placenta, once considered sterile, may serve as a conduit for this transfer. We hypothesized that the placental microbial signatures would be distinctly different from oral, fecal, or vaginal microbiomes in pregnant mice. Methods: To test this hypothesis, the obese BPH/5 mouse (n=15), which spontaneously develops a preeclampsia (PE)-like phenotype, was compared to normotensive C57 (n=8) pregnant mice. 16S rRNA gene sequencing and bioinformatic analyses were conducted to assess microbial diversity and composition from samples collected at embryonic day 18.5 (feces, oral cavity, vagina, and placenta). Results: Alpha diversity analysis revealed that oral microbiomes of both BPH/5 and C57 were significantly less diverse compared to the placental microbial signatures (p = 0.019 and <0.001, respectively). Beta diversity analysis confirmed distinct microbial communities across body sites and between strains (p < 0.001), while no significant differences were detected in placental and vaginal microbiomes (p > 0.05). Microbial composition analysis showed site-specific variations at the phylum and genus levels with Firmicutes and Bacteroidetes being dominant across all sites. BPH/5 placentas were enriched in Discussion: These findings demonstrate that the placental microbial signatures are unique in a PE-like mouse model. Further studies are needed to elucidate the functional impact of these microbial differences on maternal and fetal PE outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.